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Abstract
The controversies surrounding transgenic crops, often called Genetically Modified Organisms (GMOs), call for a
need to raise the level of public awareness of Genetic Modification (GM) technology in Africa. This should be
accomplished by educating the public about the potential benefits and risks that may be associated with this new
technology. In the last 15 years, GM crop producing countries have benefited from adoption of this new
technology in the form of improved crop productivity, food security, and quality of life. The increased income to
resource-poor farmers is a key benefit at the individual level especially as most countries using this technology are
in the developing world, including three African countries (South Africa, Burkina Faso and Egypt). Despite clear
benefits to countries and farmers who grow GMOs, many people are concerned about suspected potential risks
associated with GMOs. This sparks debate as to whether GM technology should be adopted or not. Given the
concerns regarding the safety of GMO products, thorough scientific investigation of safe application of GMOs is
required. The objective of this paper is to respond to the issues of GM agriculture in Africa and some of the issues
surrounding the adoption of GM crops between developed and developing countries. In this article, I analyse
relevant papers relating to the adoption of GM technology particularly in developing countries including the few
African countries that have adopted GM crops. The issues discussed span a wide range including: safety; potential
benefits and risks; disputes between the United States of America (USA) and the European Union (EU) over
adoption of GM crops with a focus on Africa continent. This article is concluded by summarising the issues raised
and how GM technology can be adopted for agricultural development in Africa.
Discussion
Why must GMOs be given a chance in Africa?
A growing body of evidence-based reports continue to
document increased crop yields, increased farm income,
and health and environment benefits associated with GM
crops [1-10]. In 1996, when GM crops were first officially
commercialised, six countries planted a total of 1.7 million
hectares of these crops [9]. By 2010 this had grown to 148
million hectares in 29 countries, of which 19 are from the
developing world. This 87-fold growth makes GM the fast-
est crop technology to be adopted in the history of mod-
ern agriculture. Of 15.4 million farmers that planted GM
crops in 2010, over 90% (14.4 million) are resource-poor
farmers in developing countries, including three African
countries (Burkina Faso, South Africa and Egypt), that
benefited from the adoption of GM crops [9]. For exam-
ple, almost 100,000 farmers in Burkina Faso cultivated
GM cotton on 260,000 hectares in 2010 with 126%
increase from 115,000 hectares planted in 2009. In terms
of contribution to the economy of Burkina Faso, it was
estimated that a benefit of over US$100 million per year
could be generated based on almost 30% increase in yield
[11]. Additionally, close to a 50% reduction in insecticides
sprays may be realised, thereby saving fossil fuels and low-
ering greenhouse gases emission, hence fighting against
climate change. South Africa, the first and biggest produ-
cer of GM crops in Africa, has benefitted from growing
GM crops over the past decade. They are the only African
country among the five principal countries (also India,
Argentina, Brazil and China) producing GM crops, with
63 million hectares planted in 2010 alone. The economy
of South Africa has benefited a great deal from the adop-
tion of GM technology and it has been reported to have
enhanced farm income from GM maize, GM soybean and
GM cotton by US$156 million in the period 1998 to 2006,
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with 2006 alone estimated to be US$67 million [12]. Egypt
was the first North African country to grow GM crops
commercially in 2008 with 700 hectares of GM maize
planted and the Egyptian government planning to increase
the hectarage of GM crops in future [13].
In contrast to the documented benefits of GM crops,
there are few documented cases of potential health
effects [14] or economic drawbacks [15,16] to GM crops.
However, the issues of potential risks of GMOs continue
to be raised, particularly in Europe, and the media is
being used to attract attention to the question of whether
GMO products are safe. For example, the “Flavr Savr”
tomato is a genetically modified tomato that has altered
DNA to delay ripening, thereby prolonging shelf-life [17].
It was the first GM food to be authorised for human con-
sumption in the United States and received broad cover-
age by the media even though it is not a poison or a food
known to cause illness. A GM soybean that contained a
Brazil nut allergen [18] is arguably the only incident that
got more attention from the media when GM crops were
first commercialized. The intense media coverage
resulted in cessation of further development of this parti-
cular variety due to potential health risks. In contrast,
another incident that attracted media attention was that
of a scientist that claimed a genetically engineered potato
caused a depressed immune response in rats [19], but
subsequent investigation showed that the experiment was
scientifically flawed.
It should be noted that eating conventional foods is not
risk free as they are known to contain allergies. For
example, there was no known allergy when kiwifruit were
introduced into the European and United States markets
in the 1960s, but the fruits are now known to cause aller-
gic reactions [20]. GM technology is like any other new
technology and has its merits and drawbacks. Over the
period of time that commercially available GM foods
have been produced, no studies have indicated that
GM foods are less safe than traditional counterparts.
Although merit may be given to concerns of unintended
gene flow from genetically engineered agricultural pro-
ducts, further studies are required to establish the reality
and/or scope of this and other potential environmental
risks due to GMOs. Unintended adverse effects of GMOs
on non-target species (e.g. butterflies) have been reported
to be similar to what currently exists in traditional agri-
cultural products [21]. While there are other individual
claims that GMOs could pose health risks to human
beings, most of these findings are not peer-reviewed in
international scientific journals or by any officially recog-
nised standard. Rather, these are individual works that
are being promoted on websites or by non-governmental
organisations (NGOs). Unfortunately, when issues like
these are raised and debated, many people condemn
GMOs outright based upon unverified sources and also
fail to see if there are advantages associated with the
application of GMOs.
Several international regulatory bodies including the
World Health Organisation (WHO), the Food and Agricul-
ture Organisation of United Nations (FAO) have con-
cluded that there is no scientific evidence that the
application of GM technology has resulted in substantial
human health effects or environmental problems [22,23].
For example, a British government report released by a
panel of experts found out that no verifiable ill effects have
been reported from consumption of GM food products
and that the risks to human health are very low for current
GM crops on the markets [23]. In spite of the lack of evi-
dence for potential adverse effects of GMO production,
most European countries do not grow GM crops as pre-
cautionary principle to ban GM crops has been adopted in
European legislation. This precautionary principle can be
invoked when: “potentially dangerous effects deriving from
a phenomenon, product or process have been identified,
and ...scientific evaluation does not allow the risk to be
determined with sufficient certainty” because of the insuffi-
ciency of the data or their inconclusive or imprecise nat-
ure” [24]. In other words, this precautionary principle can
be stated as: action can be taken against potential hazards
if the scientific information does not prove lack of risk.
While the use of this precautionary principle may be based
upon a lack of scientific assessments of the risks of adopt-
ing GM crops, it has been criticised due to lack of assess-
ment of economic, social and ethics aspects of GM
adoption [25]. Additionally, this precautionary principle
has been interpreted differently in international treaties,
court decisions, academic literature and government policy
reports [26]. This has effectively made it difficult to refer to
the precautionary principle as a single or collective term.
While the precautionary principle has been presented in
several versions, there is no clear existing scientific con-
sensus within the scientific community with regards to
any of the risks that may have been found or associated
with GMO products. But the question remains: Are there
books or peer-review journals that have recorded the
number of illnesses or deaths as a result of consumption
of GMO products in any part of the world? It is unfortu-
nate that many people and organisations including govern-
ment officials in Africa see GM technology as a poison
that must be avoided and not to be introduced into their
decaying traditional farming systems. Some of these pro-
blems can be attributed to lack of awareness and educa-
tion on the application of modern biotechnology among
Africans. For example, it was recently reported that scien-
tists have not effectively communicated the benefits and
risks of modern biotechnology to the Kenyans [27], hence
leading to a high level of public concern and protests
against GM crops. The failure of the scientists to play a
role in public education might be attributed to negligence
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on the part of Kenyan government or may reflect a lack of
communication and/or confidence between government
and scientists over GMOs issues. These issues should be
addressed and the public must be educated on both the
potential economic benefits of GM crops and also the gen-
eral lack of scientific evidence for health related issues
when GM crops are consumed.
Africa must be saved from hunger
Given the high level of poverty, malnutrition, hunger,
food security problems, and low agricultural productivity
in Africa, advanced technology like GM technology has
the potential to offer solutions to some of these pro-
blems. However, the controversy over the use of GM
technology remains one of the biggest threats in adopting
this new technology. The current regulatory approaches
of the United States of America (USA) and the European
Union (EU) can play an important role over adoption of
GM technology in developing countries, particularly in
Africa [22,28,29]. For example, the USA can allow com-
mercial release of GMO products based upon standard
tests such as allegenicity, digestivity and toxicity without
any regulatory barrier, whereas in the EU, GMO products
can be stopped based upon scientific uncertainty alone
without any associated evidence of risks and sufficient
testing according to the so called ‘’precautionary
principle’’.
The precautionary principle has become a political tus-
sle, without clearly defined concepts, among giant nations
[22]. This tussle has a serious impact on the African conti-
nent as to whether to adopt GM technology or not.
Reports have shown that developing countries, including
Africa, consider their trade relationships with the EU
before adopting GM crops due to the fear of losing this
market [30,31]. As a result, African governments tend to
exhibit a ‘’go slow approach’’ toward the adoption of GM
technology. This is often reflected in delayed approval of
biosafety laws required to grow GM crops, with the major-
ity of African countries lacking a functional biosafety sys-
tem [32]. An attempt to ascertain what causes delay in
biosafety law approval has attributed the delay to political
lobbying, change of administration, and the issue not
being a high priority for the policymakers [33].
Why should we fold our arms when many people are
starving, and children are dying as a result of malnutrition,
in Africa and there is an innovative technology to solve
part of the problem? For example, when about 14 million
people in Southern African countries were faced with a
food crisis due to drought, the food aid provided by the
USA was rejected by Zimbabwe and Zambia simply
because the maize was GM. People in these nations were
left to suffer from starvation as a result. Although Zim-
babwe reversed its decision after diplomatic intervention
from pro-GM countries, Zambia placed an outright ban
on GM maize from USA, stating potential health risks
associated with the food. Severe drought in East Africa,
Kenya, has resulted in recent import of GM maize due to
the shortage of maize. However, many people, led by anti-
GM activists, protested against the importation of GM
maize as they feared it would contaminate the soil and
could be harmful to the health of the citizens. Fortunately,
the importation of GM maize was cleared by the Kenyan
Cabinet after a proper safety assessment and clearance
from the National Biosafety Authority.
Apart from constraints such as inadequate infrastruc-
ture and facilities, most channels of influence that are
associated with adoption of GM technology in Africa
come mainly from EU, and their tough regulatory pre-
cautionary principle can be a major threat to commercial
export sales when African countries start producing GM
crops [22,28,31]. This is not only restricted to African
countries but other developing countries are also suffer-
ing a similar fate. Recently, the Director of the Beijing
Genomics Institute strongly advised that EU should
change its current GMO policies that hinder China and
other developing countries from enjoying full benefits of
these new agricultural technologies [34]. European
Greenpeace is arguably the most organised group in the
world that is campaigning against GMOs; they played a
key role in influencing Zambian government officials to
reject any GMO products coming into the country [22].
Any attempt to allow GMO products could mean that
organic agricultural product export sales to the EU may
be lost. While the USA considers GMO products safe
enough for human consumption, after going through
compulsory testing with their conventional counterparts,
the EU regulatory approach is probably not in best inter-
est of GMO products [29]. While no clear evidence has
been established against GM crops, the EU remains scep-
tical about the use of GM crops despite spending more
than $425 million on studying the safety of GM crops
over the past 25 years [35].
Moreover, it is unclear what roles international organi-
sations such as the World Trade Organisation (WTO)
and the Convention on Biological Diversity (CBD) are
playing in mediating the disputes between the USA and
the EU as there does not seem to be cooperation on con-
tending issues. Rather, it appears that multiple factors
(political, economic, institutional, legal, historical and
cultural) have combined together in a manner that
undermines potential cooperation and mutual benefit
between the two parties [36]. This lack of cooperation
affects many poor countries in decision making on these
new agricultural technologies. Why is there such a divide
or lack of common interest to promote and encourage
the fastest technology in the history of modern agricul-
ture to fight poverty, malnutrition, hunger and food inse-
curity in Africa? Answering this question is beyond the
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scope of this article. Perhaps, this question can be
answered as more knowledge about GM technology
becomes available and when assessing the global benefit
of this new technology becomes a reality. Current evi-
dence shows that GM technology has a great potential to
improve agricultural productivity and farmers’ livelihood
in developing countries. Therefore, GM technology must
be allowed to play a part in alleviating hunger and pov-
erty in Africa.
Safety is paramount: America and others leading the way
It is important to ensure the safety of all citizens that
consume GM foods either in Africa or any part of the
world. Not many countries are using GMOs in agricul-
tural production around the world due to health and
environmental concerns associated with the application
of GMOs. The USA is one of the few developed countries
growing GM crops on a commercial basis. More than 70
percent of some foods in the USA contain GMOs [37],
yet no American citizen or others that have consumed
their foods have been confirmed seriously ill or dead as a
result of GMO consumption.
In view of the fact that no global consensus has been
reached over completely safe application of GMOs and
as the need to regulate or control GMO products become
more important, the USA can be a good example for
Africa and the rest of the world. The USA appears to be
a lead country in safe application of GMO products with
the United States Department of Agriculture (USDA)
reporting that 93 percent of all soybeans, 78 percent of
all cotton, and 70 percent of all corn grown in the USA
in 2010 were genetically modified to be herbicide tolerant
[38]. In fact, USA regulatory bodies have determined that
GMO foods are “substantially equivalent” to conventional
foods. Before any GMO products are released for human
consumption, they are compared with traditional coun-
terparts in a variety of chemical, genetic, biochemical,
compositional, nutritional and environmental tests as
well as comparison with known allergens [39]. The USA
Food and Drug Administration (FDA) monitors every
product made up of GMOs for comprehensive safety and
environmental testing. Other GM producing countries,
including Canada, Australia, China, and Argentina are
carrying out similar tests to ensure that GMO products
are safe for human consumption.
Although, the USA’s FDA cannot be compared with
majority of food & drug regulation departments in African
countries which are without sophisticated equipment to
do thorough testing and analysis, some of these countries
have effective regulatory system with excellent track
records in food safety. With support from developed
countries, it should be possible to increase local capacity
for testing in Africa and this should ensure safe delivery of
GMO products while taking necessary precautions. The
USA and other countries are good examples to follow
when it comes to adoption of GM technology. After all, it
is how this technology is used that determines whether it
is risky, good, or beneficial. Therefore, as with any technol-
ogy, continued evaluation of GM technology in terms of
safety and benefits will be important as more knowledge
becomes available. African governments can learn to fol-
low the same procedures that other countries are already
employing to ensure the safety of their citizens when
GMO products become available in Africa.
Working towards common interest: embracing the Gene
Revolution in Africa
Over four decades the Green Revolution was implemen-
ted and African countries were bypassed without any
documented benefits. In contrast, Asian countries have
benefited in terms of improved seeds, chemicals, pesti-
cides and inorganic fertilizers. This has brought about
phenomenal successes in boosting crop production in
corn, wheat and rice [40]. The emergence of the Gene
Revolution is assumed to play a significant role whereas
the Green Revolution was not able to deliver in Africa.
The slow embracement of the Gene Revolution in Africa,
particularly GM technology, is the lack of access for ben-
eficiaries such as farmers and scientists to GM crops.
This lack of access is, at least in part, due to international
influence against GMOs and this international influence
remains fundamental to the successful adoption of GM
technology in Africa.
There are a lot of issues affecting the adoption of GM
technology. These require a concerted effort from African
governments and developed countries to ensure successful
transfer of the technology to the beneficiaries. In this
regard, one of the major challenges which can delay access
to GM crops is dealing with intellectual property right
(IPR) issues. GM technology is currently being applied in
production of the main commercial crops such as cotton,
corn and soybean. Clearly this creates the largest profit for
the biotech companies (e.g. Monsanto). However, it is dif-
ficult to access the technology in developing countries as
biotech companies are often reluctant to invest in the
development of this new technology in Africa. Most of the
developing countries (especially Africa) do not have strong
and effective laws to protect IPR and the legal systems can
be very poor, this may partially explain why biotech com-
panies are not attracted to African countries. Given the
problem of the IPR logjam, one can imagine a lengthy per-
iod before innovative technologies that have potential ben-
efits for orphan crops (e.g. millet, cassava, potato, sweet
potato, yam, banana, cowpea and sorghum) can be realized
as GM crops in African countries. Some hope may be on
the horizon as the African Agricultural Technology Foun-
dation (AATF) is working towards facilitating and promot-
ing partnerships between the public and private sector to
Adenle BMC Research Notes 2011, 4:388
http://www.biomedcentral.com/1756-0500/4/388
Page 4 of 6
ensure that resource-poor farmers have free access to agri-
cultural technologies including GM technology. Efforts are
being made by AATF in partnership with other institu-
tions towards developing GM crops that can benefit
African farmers. For example, African scientists in colla-
boration with other scientists in developed countries are
carrying out research on orphan crops such as GM
banana, GM cassava and GM cowpea with field trials
being carried out in Uganda and Nigeria respectively.
Other than IPR issues, the adoption of GMOs is strongly
influenced by developed countries particularly the USA
and EU. The USA and EU clearly demonstrate unequal
levels of trust of the safe application of GMOs. This can
be an obstacle for adopting this new technology in Africa.
While the European influence in Africa seems stronger
than the American influence, particularly in trade partner-
ship, economic and political power should not stand in
the way of new technology. Apart from foreign aid that
comes from the EU, the majority of African countries have
closer cultural ties with Europeans (stemming from
the colonial era) than Americans. Thus, the majority of
African countries are more likely to stick to the views and
practices of European systems [22]. However, such prac-
tices or systems must not dominate agricultural policies in
Africa. Because agricultural practices are a matter of life
and death in Africa, they must be sustained and improved
to feed the poor continent. The developed countries like
the USA, the EU and others should work in common
interest of delivering GM technology that has potentials to
improve agricultural productivity, health and food security
in Africa.
Africa must take action
Agriculture plays a significant role in the economy of
African countries in terms of gross domestic product
(GDP), promoting international trade, industrial develop-
ment and creation of job opportunities. Therefore, there
is an urgent need to improve agricultural production.
GM technology can be a part of the solutions in cases
where traditional methods of farming have been less effi-
cient. The potential benefits of GM crops toward alleviat-
ing poverty and hunger, improving agricultural
productivity, health, food security and creating a friendly
environment cannot be overemphasised. The adoption of
GM technology is at its initial stages in Africa and is cur-
rently faced with several constraints such as lack of infra-
structures, inadequate human resource capacity, poor
education, biosafety regulation, intellectual property
rights and many others. A concerted effort from devel-
oped countries including international organisations
must be put in place to ensure that Africa benefits from
this new technology. African governments must also be
involved in solving these problems themselves and they
should come up with coherent strategy to adopt modern
biotechnology including educating the public, farmers
and government institutions, the media and private com-
panies, and to increase understanding of GM technology.
Part of the strategy must include adoption of common
policies and a regional platform through which African
governments can engage in dialogue and develop a com-
mon biotechnology regulatory approach. Africa might
pay a huge price in many years to come if the continent
continues to depend on outsiders before making deci-
sions that determine their future. Europeans are well fed
and may not necessarily require GM technology to boost
their crop productions, but African farmers need fast
technology that can solve part of their agricultural
problems.
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